William Lorelli

460 total citations
10 papers, 397 citations indexed

About

William Lorelli is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, William Lorelli has authored 10 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in William Lorelli's work include Platelet Disorders and Treatments (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). William Lorelli is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). William Lorelli collaborates with scholars based in United States. William Lorelli's co-authors include Shaker A. Mousa, Peter A. Campochiaro, Thomas M. Reilly, Martin Thoolen, Mark S. Forsythe, P. Patrick Cleary, Šárka O. Southern, David Cue, Joanne M. Smallheer and Peter J. Southern and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and Journal of Cellular Biochemistry.

In The Last Decade

William Lorelli

10 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Lorelli United States	8	134	111	104	101	80	10	397
Sheila Waugh United Kingdom	8	44 0.3×	42 0.4×	18 0.2×	10 0.1×	18 0.2×	17	358
Jerzy W. Kupiec‐Weglinski United States	15	101 0.8×	33 0.3×	3 0.0×	56 0.6×	45 0.6×	26	554
Ylva Härdig Sweden	10	70 0.5×	228 2.1×	3 0.0×	9 0.1×	27 0.3×	12	475
James Archer United Kingdom	13	96 0.7×	44 0.4×	5 0.0×	24 0.2×	57 0.7×	38	386
A. Yun United States	10	72 0.5×	3 0.0×	176 1.7×	46 0.5×	67 0.8×	13	483
Ujjaldeep Jaggi United States	14	120 0.9×	7 0.1×	70 0.7×	5 0.0×	19 0.2×	32	483
Thiel Hj Germany	9	76 0.6×	6 0.1×	146 1.4×	6 0.1×	125 1.6×	68	327
Shenghe Cai United States	7	62 0.5×	116 1.0×	5 0.0×	9 0.1×	10 0.1×	9	373
Minjian Ni United States	10	132 1.0×	5 0.0×	81 0.8×	12 0.1×	55 0.7×	15	496

Countries citing papers authored by William Lorelli

Since Specialization

Citations

This map shows the geographic impact of William Lorelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Lorelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Lorelli more than expected).

Fields of papers citing papers by William Lorelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Lorelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Lorelli. The network helps show where William Lorelli may publish in the future.

Co-authorship network of co-authors of William Lorelli

This figure shows the co-authorship network connecting the top 25 collaborators of William Lorelli. A scholar is included among the top collaborators of William Lorelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Lorelli. William Lorelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Cue, David, Šárka O. Southern, Peter J. Southern, et al.. (2000). A nonpetide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin α5β1-fibronectin-M1 protein complexes. Proceedings of the National Academy of Sciences. 97(6). 2858–2863. 86 indexed citations

2.

Mousa, Shaker A., William Lorelli, Seema Mohamed, et al.. (1999). αvβ3 Integrin Binding Affinity and Specificity of SM256 in Various Species. Journal of Cardiovascular Pharmacology. 33(4). 641–646. 22 indexed citations

3.

Mousa, Shaker A., William Lorelli, & Peter A. Campochiaro. (1999). Role of hypoxia and extracellular matrix‐integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. Journal of Cellular Biochemistry. 74(1). 135–143. 6 indexed citations

4.

Mousa, Shaker A., William Lorelli, & Peter A. Campochiaro. (1999). Role of hypoxia and extracellular matrix‐integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. Journal of Cellular Biochemistry. 74(1). 135–143. 147 indexed citations

5.

Mousa, Shaker A., Richard E. Olson, Jeffrey M. Bozarth, et al.. (1998). Oral Antiplatelet Efficacy and Specificity of a Novel Nonpeptide Platelet GPIIb/IIIa Receptor Antagonist, DMP 802. Journal of Cardiovascular Pharmacology. 32(2). 169–176. 13 indexed citations

6.

Mousa, Shaker A., Jeffrey M. Bozarth, William Lorelli, et al.. (1998). Antiplatelet Efficacy of XV459, A Novel Nonpeptide Platelet GPIIb/IIIa Antagonist: Comparative Platelet Binding Profiles with c7E3. Journal of Pharmacology and Experimental Therapeutics. 286(3). 1277–1284. 32 indexed citations

7.

Mousa, Shaker A., Mark S. Forsythe, William Lorelli, et al.. (1996). Novel nonpeptide antiplatelet glycoprotein llb/llla receptor antagonist, DMP754. Coronary Artery Disease. 7(10). 767–774. 41 indexed citations

8.

Mousa, Shaker A., et al.. (1994). Intravenous antiplatelet efficacy and safety of the platelet GPIIb/IIIa antagonist, DMP 728 in anesthetized dogs. Thrombosis Research. 76(2). 109–119. 8 indexed citations

9.

Mousa, Shaker A., Mark S. Forsythe, William Lorelli, et al.. (1993). Antiplatelet Efficacy and Specificity of DMP728, a Novel Platelet GPIIb/llla Receptor Antagonist. Cardiology. 83(5-6). 374–382. 40 indexed citations

10.

Reilly, Thomas M., et al.. (1993). Monoclonal antibodies against a recombinant form of plasminogen activator inhibitor-1: Effects on tissue plasminogen activator neutralizing and vitronectin binding properties. Fibrinolysis and Proteolysis. 7(6). 373–378. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact